Ryze Mushroom Coffee and Anxiety: Reishi Research and Caffeine
This page does not present RYZE as an anxiety treatment. Its coffee contains caffeine, and the manufacturer lists Reishi in a blend; neither fact predicts how a particular person with anxiety will feel.
A Reishi study asked about stress in a narrow group
A 2024 randomized, double-blind study enrolled 78 female college students, average age about 21. Participants received 500 mg or 1,000 mg daily of a Reishi (Ganoderma lucidum) supplement or placebo for 30 days. The authors reported improvements in selected self-reported anxiety, depression, vitality, and wellbeing scores in the higher-dose group.
This is a small, short study in a specific student population using a defined supplement. It does not establish treatment for an anxiety disorder, and its dose and preparation cannot be mapped to an undisclosed amount in RYZE coffee.
Caffeine can also matter to how a cup feels
The FDA says caffeine effects vary with individual sensitivity, medications, and health circumstances. Its consumer guidance lists anxiety and jitters among symptoms that can occur with too much caffeine. The updated RYZE label lists about 50 mg per Medium Roast serving and about 90 mg for Dark Roast; include other drinks, foods, and medicines when considering total intake.
Those figures describe caffeine content, not an anxiety outcome. A lower amount does not mean the drink is anxiety-safe for everyone, and a subjective response cannot identify whether caffeine, sleep, expectation, or another factor caused it.
A caffeine response is not a diagnosis
A person may notice restlessness, a racing feeling, or difficulty settling after caffeine, but those sensations alone do not identify an anxiety disorder or establish that coffee caused every symptom. Timing, amount, other caffeine sources, sleep, stress, medication, and health conditions can all matter. The manufacturer's per-serving number is useful for describing one declared input; it does not predict an individual's response.
If someone is trying to understand a pattern, a neutral record can capture the drink, serving, time, other caffeine, sleep, and symptoms. That record may help a clinician ask more focused questions. It should not be used to self-diagnose, replace care, or support a claim that the mushroom blend has an anxiolytic effect. Persistent or severe symptoms deserve professional attention.
What a trial would have to distinguish
A trial of a finished coffee would need to separate its caffeine from its mushroom ingredients and compare the product with an appropriate control. It would also have to define the participant group, dose, duration, and anxiety outcome in advance. Short-term stress ratings in a small student sample cannot establish treatment for a diagnosed anxiety condition, and a result for one Reishi supplement cannot be transferred to a multi-ingredient coffee with an undisclosed amount.
The study discussed in this article is an early research question, not a clinical recommendation. It involved a specific group of female college students, a named supplement, and a short intervention. A different population, dose, or outcome could produce a different finding. Repetition and independent study are needed before a narrow result is treated as a reliable effect.
Choose evidence that matches the claim
Words such as calm, stress support, or anxiety relief can blur several different ideas: a self-reported mood, a physiological marker, sleep quality, and symptoms of a clinical disorder. Ask which of these was measured and whether the study's participants had the condition named in the claim. An ingredient mechanism or animal experiment may explain why researchers are interested, but it is not proof that a packaged drink helps a person feel calmer.
This guide cannot recommend RYZE or another supplement for anxiety. If caffeine appears to be a concern, discuss the product and total intake with a health professional, especially when medicines or a diagnosed condition are involved. Do not stop prescribed treatment or change medication based on a product claim or an ingredient study.
Keep caffeine and a mushroom claim separate
If a reader notices anxiety-like symptoms after a caffeinated drink, the listed caffeine amount is one detail to discuss, not a diagnosis or a complete explanation. Other drinks, foods, medicines, sleep, and health conditions may matter. The 50 mg and 90 mg manufacturer figures are per serving; using more powder or combining products changes the total that a person is considering.
A careful comparison asks whether a study controlled caffeine and tested the finished product. If not, it cannot isolate a Reishi effect from the coffee base or other ingredients. The evidence summarized on this page does not establish that RYZE reduces anxiety or should be used in place of mental-health care.
When to get individual help
The Reishi study is preliminary ingredient evidence, while the caffeine figure is a manufacturer statement. Neither demonstrates that RYZE treats anxiety or determines whether it is appropriate for a particular person. For persistent or severe symptoms, discuss care with a qualified health professional.
What to check for this question
- Check the roast-specific caffeine amount and count other sources.
- Look for anxiety diagnoses and validated outcomes rather than general mood language.
- Do not replace prescribed treatment with a beverage or supplement.